There are 12 million shares of TKMR and some one is following this stock.
Right now there could be news of the court case. A positive result there could move this stock higher soon.
There is one phase one clinical trial that started in 2009 and a new Clinical trial was just OKed by the FDA for TKMR for Cancer with the National Cancer Institute working with TKMR. That looks good.